Can we define a group of pit viper victims who are at low risk for hematologic venom effects (fibrinogen degradation and/or platelet destruction) and spare these patients the time and expense of serial laboratory testing?
In this study, we sought to determine whether it was possible to limit the practice of ordering coagulation studies to those patients suffering severe envenomation, rattlesnake envenomation, or both.
